Jon Zinman

Insider Reports History

Location
Greenwich, CT
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jon Zinman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keenova Therapeutics plc Director Ordinary Shares 8,031 $712,751 $88.75 01 Jan 2026 By JZ Advisors LLC
Keenova Therapeutics plc Director Restricted Stock Units 35,570 01 Jan 2026 Direct

Insider Reports Filed by Jon Zinman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465926000785-zinman-jon-2026-01-01 Keenova Therapeutics plc 01 Jan 2026 2 $0 4 Director 05 Jan 2026, 18:05
Mallinckrodt plc 14 Aug 2025 1 $0 4 Director 18 Aug 2025, 21:07
Mallinckrodt plc 31 Jul 2025 1 $0 4 Director 04 Aug 2025, 20:53
NONE Mallinckrodt plc 01 Jan 2025 2 $0 4 Director 02 Jan 2025, 17:05
NONE Mallinckrodt plc 19 Feb 2024 1 $0 4 Director 20 Feb 2024, 16:20
NONE Mallinckrodt plc 14 Nov 2023 0 $0 3 Director 22 Nov 2023, 18:53